v3.26.1
Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2026
Intangible Assets [Abstract]  
Schedule of Intangible Assets

Intangible assets consisted of the following:

 

Intangible Assets  March 31,
2026
   December 31,
2025
 
Licenses          
Non-Exclusive License Agreement  $179,821   $179,821 
Various generic drugs   
-
    736,983 
Four generic drugs (Encore)   
-
    1,308,270 
Needleless Syringe License   26,060    26,060 
Patents   48,420    48,420 
Mineral rights and exploratory   48,416,474    
-
 
Total intangible assets, net  $48,670,775   $2,299,554